Yes, I assume we will be getting an RNS at some stage regarding the management structure. Not sure whether Dr Franco Di Muzio interim role as Chairman will become permanent. I had wondered whether our latest non-exec Dr Stéphane Méry may be involved in any new structure. I guess time will tell.
amendment to the start date mentioned, Clinical Trials states September (so can only assume Tuesday).
I was working on the basis that September would be the month for news. Hoping for: an update on phase III (RNS stated autumn for 1st dosing, hopefully early autumn) I noticed clinical trials processed the record on the 26th of August, Term sheet agreement details, Chairman update, possible an update on IPP-204106 Either way the official trial start date is Tuesday. So you never know Monday could be the start of the updates rolling out, and the end of the holidays season as well. All IMHO of course.
We've not heard anything this month...
Yes could well do - will be very interesting to see the terms.
Think we will see more info on the details of finance for stage 3 this week
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.